How is silent ‘non-alcoholic fatty liver disease’ epidemic perceived in India? A community based cross sectional study


  • Anurag Lavekar Department of Gastroenterology, Triveni Hospital, Nanded, Maharashtra
  • Pradeep Tarikere Satyanarayana Department of Community Medicine, S.D.U.A.H.E.R., S.D.U.M.C., Kolar, Karnataka
  • Anagha Lavekar Department of Obstetrician and Gynecology, Triveni Hospital, Nanded, Maharashtra



NAFLD, Perceptions, Knowledge


Background: One of the diseases assuming fast importance is non-alcoholic fatty liver disease (NAFLD) which is a clinical syndrome characterized by predominant macrovesicular steatosis of the liver which is an umbrella term for a range of liver conditions affecting people who drink little or no alcohol. Only mild to moderate elevation of serum transaminases which could be only laboratory abnormality found in NAFLD. So with this background, the study was started with the objectives of assessing the perceptions of general population regarding NAFLD and factors influencing perceptions of general population regarding NAFLD.

Methods: It was a community based cross sectional study carried out for a period of 12 months from January 2018 to December 2018 among in Nanded, Maharashtra. Around 422 households were involved after simple random sampling. To assess perceptions a pretested semi-structured questionnaire was used which had 27 questions. All data collected was entered in Microsoft excel and analysed using SPSS v22.

Results: Out of 422 participants, 147 (34.8%) were in the age group of 31-40 years, 333 (78.9%) were male participants, 179 (42.5%) were graduates, 284 (67.3%) belonged to joint family, 140 (33.2%) belonged to Modified BG Prasad classification 2018. 181 (42.9%) had satisfactory perception regarding NAFLD. Females, participants aged more than 40 years, nuclear family participants had better scores.

Conclusions: The present study showed majority of the participants had little awareness of NAFLD regardless of their age, gender, or educational status. Awareness of NAFLD must be promoted for prevention, early detection, and treatment especially counseling by primary care physicians preponderant influence in preventive strategy for NAFLD breaking the chain of disease progression.

Author Biography

Pradeep Tarikere Satyanarayana, Department of Community Medicine, S.D.U.A.H.E.R., S.D.U.M.C., Kolar, Karnataka

Assistant professor,Department of Community Medicine ,SDUAHER,SDUMC,Kolar


Singh SP, Nayak S, Swain M, Rout N, Mallik RN, Agrawal O, et al. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Tropical Gastroenterology: official J Digest Dis Foundation. 2004;25(2):76-9.

Singh S, Kuftinec GN, Sarkar S. Non-alcoholic fatty liver disease in South Asians: a review of the literature. J ClinTransl Hepatol. 2017;5(1):76.

Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1):47-64.

Zhu JZ, Dai YN, Wang YM, Zhou QY, Yu CH, Li YM. Prevalence of nonalcoholic fatty liver disease and economy. Digestive diseases and sciences. 2015;60(11):3194-202.

Luthra A, Nigam P, Misra A. Metabolic correlation and management strategies of non-alcoholic fatty liver disease: An Asian Indian perspective. Diabetes Metab Syndr: Clin Res Rev. 2007;1(4):279-85.

Praveenraj P, Gomes RM, Kumar S, Karthikeyan P, Shankar A, Parthasarathi R, et al. Prevalence and predictors of non-alcoholic fatty liver disease in morbidly obese south Indian patients undergoing bariatric surgery. Obesity Surg. 2015;25(11):2078-87.

Duseja A, Das A, Das R, Dhiman RK, Chawla Y, Bhansali A, et al. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. Digest Dis Sci. 2007;52(9):2368-74.

Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Digest Dis. 2010;28(1):155-61.

Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature Rev Gastroenterol Hepatol. 2018;15(1):11.

Duseja A, Chalasani N. Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD). Hepatol Int. 2013;7(2):755-64.

Majumdar A, Misra P, Sharma S, Kant S, Krishnan A, Pandav CS. Prevalence of nonalcoholic fatty liver disease in an adult population in a rural community of Haryana, India. Indian J Public health. 2016;60(1):26.

Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni C. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Prac. 2009;84(1):84-91.

Juneja A. Non-alcoholic fatty liver disease (NAFLD)—the hepatic component of metabolic syndrome. JAPI. 2009;57:201.

Anurag L, Aniket S, Shalik J, Amarja L, Dhananjay R, Sachin J. Non-alcoholic fatty liver disease prevalence and associated risk factors–A study from rural sector of Maharashtra. Trop Gastroenterol. 2015;36(1):25-30.

Pandey VK, Aggarwal P, Kakkar R. Modified BG Prasads Socio-economic Classification-2018: The need of an update in the present scenario. Indian J Community Health. 2018;30(1):82-4.

Lim JU, Lee JH, Kim JS, Hwang YI, Kim TH, Lim SY, et al. Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients. Int J Chronic Obstruc Pulmonary Dis. 2017;12:2465.

Ghevariya V, Sandar N, Patel K, Ghevariya N, Shah R, Aron J, et al. Knowing what’s out there: awareness of non-alcoholic fatty liver disease. Frontiers Med. 2014;1:4.

Leung CM, Lai LS, Wong WH, Chan KH, Luk YW, Lai JY, et al. Non‐alcoholic fatty liver disease: An expanding problem with low levels of awareness in Hong Kong. J Gastroenterol Hepatol. 2009;24(11):1786-90.

Wieland AC, Mettler P, McDermott MT, Crane LA, Cicutto LC, Bambha KM. Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk. J Clinical Gastroenterol. 2015;49(1):6-10.

Zhang W, Chao S, Chen S, Rao H, Huang R, Wei L, et al. Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Office Employees in Beijing, China. Digest Dis Sci. 2019;64(3):708-17.

Briscoe C, Aboud F. Behaviour change communication targeting four health behaviours in developing countries: a review of change techniques. Soc Sci Med. 2012;75(4):612-21.

Wakefield MA, Loken B, Hornik RC. Use of mass media campaigns to change health behaviour. Lancet. 2010;376(9748):1261-71.




How to Cite

Lavekar, A., Satyanarayana, P. T., & Lavekar, A. (2019). How is silent ‘non-alcoholic fatty liver disease’ epidemic perceived in India? A community based cross sectional study. International Journal Of Community Medicine And Public Health, 6(12), 5256–5261.



Original Research Articles